Most importantly, 1p/19q-codeleted and IDH-mutant tumors present a better clinical outcome, while GBM IDH-wild type presents the worst prognosis, being the most common (50–60%) and the most lethal brain tumors [7,8]. This evidence concerns the gene IDH1 and brain neoplasm.